Zimmer Biomet appointed Device Technologies as an exclusive distributor in Australia and New Zealand for its sports medicine and surgical product portfolios, beginning in April, with foot/ankle and trauma portfolios to follow in May.
Device Technologies has 28 years of experience in the orthopedic market in Australia and New Zealand. In 2019, the company’s orthopedic business had over 55% market share in Australia’s sports medicine market.
Zimmer Biomet’s product offerings will complement Device Technologies’ portfolio, encompassing products and technologies, education, technical service and clinical support. Presently, 85% of orthopedic surgeons in Australia and New Zealand are Device Technologies customers.
“Partnering with Zimmer Biomet is an exciting step forward for Device Technologies. We are confident in the shared values between the two companies and that Zimmer Biomet’s product offering will complement our orthopaedic product portfolio and service Device Technologies customers well,” said Mick Trevaskis, Device Technologies CEO. “It’s a partnership that will see both companies proceed well together into the future.”
Zimmer Biomet appointed Device Technologies as an exclusive distributor in Australia and New Zealand for its sports medicine and surgical product portfolios, beginning in April, with foot/ankle and trauma portfolios to follow in May.
Device Technologies has 28 years of experience in the orthopedic market in Australia and New Zealand. In 2019,...
Zimmer Biomet appointed Device Technologies as an exclusive distributor in Australia and New Zealand for its sports medicine and surgical product portfolios, beginning in April, with foot/ankle and trauma portfolios to follow in May.
Device Technologies has 28 years of experience in the orthopedic market in Australia and New Zealand. In 2019, the company’s orthopedic business had over 55% market share in Australia’s sports medicine market.
Zimmer Biomet’s product offerings will complement Device Technologies’ portfolio, encompassing products and technologies, education, technical service and clinical support. Presently, 85% of orthopedic surgeons in Australia and New Zealand are Device Technologies customers.
“Partnering with Zimmer Biomet is an exciting step forward for Device Technologies. We are confident in the shared values between the two companies and that Zimmer Biomet’s product offering will complement our orthopaedic product portfolio and service Device Technologies customers well,” said Mick Trevaskis, Device Technologies CEO. “It’s a partnership that will see both companies proceed well together into the future.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
